Pressure Builds On Neulasta As EMA Accepts Biosimilar Filings
This article was originally published in The Pink Sheet Daily
Two versions of pegfilgrastim are under review at the European agency's scientific committee.
You may also be interested in...
Roche plans to appeal against a penalty imposed by the Romanian competition authorities for implementing strategies that were said to delay the entry of competing biosimilar and generic products.
The EU association representing parallel traders says cheaper parallel imports are vital in keeping medicines affordable for member states.
The latest drug safety actions by the European Medicines Agency affect products for dermatological use and vaginal atrophy.